Dr. Keith Dawkins and Dr. Takahiro Uchida to join the Company
NATICK, Mass., Oct. 26 /PRNewswire-FirstCall/ -- Boston Scientific today announced that Keith Dawkins, M.D., and Takahiro Uchida, M.D., will be joining the Company's Clinical Sciences organization.
Dr. Dawkins will serve as Senior Vice President and Associate Chief Medical Officer, sitting on both the Clinical Leadership team and the Company's Operating Committee. He is an internationally known senior interventional cardiologist at Southampton University Hospital in England, and a former President of the British Cardiovascular Society. He trained in medicine at London University (Guy's Hospital), and in cardiology at the Brompton Hospital (London), John Radcliffe Hospital (Oxford), and Stanford University Medical Center. He has served as an advisor to the Department of Health in the United Kingdom, and he has worked closely with a number of regulatory agencies there, including the Medicines and Healthcare Products Regulatory Agency (MHRA) and the National Institute for Clinical Excellence (NICE).
He will be responsible for leading the medical input process for the Company's Interventional Cardiology, Peripheral Intervention and Neurovascular businesses. He will also participate in the formulation and execution of technology strategies for both internal research and development, as well as business development activities. In addition, he will oversee development and dissemination of scientifically based education materials to inform customers and regulators.
"We are delighted to have Dr. Dawkins joining us," said Donald S. Baim,
M.D., Boston Scientific's Chief Medical and Scientific Officer. "He is a
well-published scientific contributor who has been actively involved in the
development of the TAXUS(R) Stent System. He is also a respected medical
lecturer who is universally recognized for his keen insights into a broad
variety of cardiology and cardiology device-related i
'/>"/>
| SOURCE Boston Scientific Corporation Copyright©2007 PR Newswire. All rights reserved |